Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade

BACKGROUND & AIMS: Immune checkpoint blockade (ICB) has been approved for treatment of hepatocellular carcinoma (HCC). However, many patients with advanced HCC are non-responders to ICB monotherapy. Cytotoxic chemotherapy has been proposed to modulate the tumor microenvironment (TME) and sensiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwong, Tsz Tung, Wong, Chi Hang, Zhou, Jing Ying, Cheng, Alfred Sze Lok, Sung, Joseph Jao Yiu, Chan, Anthony Wing Hung, Chan, Stephen Lam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876565/
https://www.ncbi.nlm.nih.gov/pubmed/33604533
http://dx.doi.org/10.1016/j.jhepr.2020.100224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876565/
https://www.ncbi.nlm.nih.gov/pubmed/33604533
http://dx.doi.org/10.1016/j.jhepr.2020.100224

Ejemplares similares